The global Point-of-Care (POC) Infectious Disease Diagnostics market in terms of revenue was estimated to be worth $1,864.6 million in 2022 and is poised to reach $6,854.2 million by 2030, growing at a CAGR of 14.5% from 2023 to 2030. Diagnostic testing is performed on samples right there at the bedside, allowing doctors to make a quick diagnosis and formulate a treatment strategy on the spot. As the immune system weakens, it becomes increasingly important to make a prompt diagnosis of infectious diseases. The medical result of treating a disease can be greatly affected by its early detection, which is made possible by point-of-care diagnosis. Innovative functions, such as the ability to be used on the go, are combined with cutting-edge technologies to create point-of-care diagnostics. In the United States, the Food and Drug Administration (FDA) is in charge of regulating the distribution of diagnostics used at the point of care. These products are governed not only by the FDA but also by the Clinical Laboratory Improvement Amendments (CLIA).
What is New Additions in 2023?
✔ Detailed industry outlook
✔ Additional information on company players
✔ Customized report and analyst support on request
✔ Recent market developments and it’s futuristic growth opportunities
✔ Customized regional/country reports as per request
Request a Sample Report @ https://www.coherentmarketinsights.com/insight/request-sample/63
Point-of-care testing is advantageous in terms of both efficiency and cost-effectiveness because of the many advantages it offers, such as the elimination of the need for expensive and time-consuming laboratory analysis, the simplicity of the testing procedure, and the low cost of the tests themselves. CoaguChek Pro II, Uni-Gold HIV, Accu-Chek Aviva metre, Alere I Influenza A & B, OneTouch Verio Flex, and ICON SC Strep A are just some of the point-of-care diagnostics that are currently on the market.
The point-of-care infectious disease diagnostics market is anticipated to expand thanks to developments in point-of-care diagnostics technology.
Testing in a centralized laboratory is now considered the gold standard in biochemistry, haematology, and diagnostics. Numerous benefits, such as portability to far-flung locations, technological advancements, and reduced costs, are associated with point-of-care diagnostics. Patients can use the devices themselves as they are small and portable. Fingerstick and capillary samples are connected directly to the instrument, eliminating the need for separate sample containers. The future of point-of-care diagnostics is brighter than ever thanks to innovations like lateral flow and the incorporation of a wide range of molecular assays. Among the most popular products offered by industry heavyweights like Alere and Roche are immunoassays, which are both affordable and quick to yield results. More so, in 2014, BD FACSPresto, a point-of-care system, was made available by Becton, Dickinson and Company for the treatment of HIV/AIDS. Both CD4 T lymphocyte count and haemoglobin S.E.R. are reported as a percentage. In addition, in January of 2017, the Infectious Disease Research Institute (IDRI) developed a fusion antigen that is now a part of a Chagas disease diagnostic test made by InBios International, Inc.
Demand for point-of-care infectious disease diagnostics is anticipated to be bolstered by government and private sector initiatives and funding over the forecast period.
In order to offer efficient diagnostic and treatment options for infectious diseases, numerous organizations and governments are investing in research and development. Case in point: in 2016, the Bill & Melinda Gates Foundation provided funding to QuantuMDx Group in order to further develop and test the company’s CAPTURE-XT pathogen concentration technology and Q-POC molecular diagnostic platform for fast low cost detection of tuberculosis. The Global Challenges Research Fund provided $1.85 million to a project led by the University of Glasgow in January 2018. (GCRF). In order to facilitate prompt diagnosis and treatment, this project will create additional tests for parasitic diseases and point-of-care testing in far-flung areas.
However, the growth of the market could be stymied by the constraints inherent in point-of-care testing, such as the need for precise procedures and timing, as well as the use of distinct methodologies from laboratory testing that could yield different test results. In addition, a well-thought-out inventory system is essential in outlying areas to forestall spoilage, stockouts, and expiration problems, all of which can stunt market expansion.
Danaher Corp., Abbott Labs., Alcon Labs., Hoffman-La Roche Ltd., Becton, Dickinson and Company, Trinity Biotech Plc, AccuBioTech Co., Ltd., and Cardinal Health, Inc. are all significant players in the point-of-care infectious disease diagnostics market.
Limited Period Offer | Report Available Now at UP TO 45% off Discounted Pricing @
Single User License : https://www.coherentmarketinsights.com/promo/buynow/63
Multi Users License : https://www.coherentmarketinsights.com/promo/buynow/63
Corporate Users License : https://www.coherentmarketinsights.com/promo/buynow/63
Benefits on Coherent Market Insights study is going to provide?
★ 2023 Latest industry influencing trends and development scenario
★ To Size powerful market opportunities
★ Key decision in planning and to further expand market share
★ Identify Key Business Segments, Market proposition & Gap Analysis
★ Assisting in allocating marketing investments
★ Updated Methodology of Coherent Market Insights
Table of Contents
- Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Technology
- Market Snippet, By Application
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- PEST Analysis
- Market Dynamics
- Global Point of Care Infectious Disease Diagnostics Market, By Technology, 2017 – 2030 (US$ Mn)
- Introduction
- Market Share Analysis, 2016 and 2030 (%)
- Y-o-Y Growth Analysis, 2016 – 2030
- Segment Trends
- Lateral Flow
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Agglutination Assays
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Flow-Through
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Solid Phase
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Introduction
- Global Point of Care Infectious Disease Diagnostics Market, By Application, 2017 – 2030 (US$ Mn)
- Introduction
- Market Share Analysis, 2016 and 2030 (%)
- Y-o-Y Growth Analysis, 2016 – 2030
- Segment Trends
- HIV
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Tropical Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Liver Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Inflammatory Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Respiratory Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Hospital Associated Infections (HAIs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Sexual Health Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Introduction
- Global Point of Care Infectious Disease Diagnostics Market, By End User, 2017 – 2030 (US$ Mn)
- Introduction
- Market Share Analysis, 2016 and 2030 (%)
- Y-o-Y Growth Analysis, 2016 – 2030
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Home-Care Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Introduction
- Global Point of Care Infectious Disease Diagnostics Market, By Regions, 2017 – 2030 (US$ Mn)
- Introduction
- Market Share Analysis, By Region, 2016 and 2030 (%)
- Y-o-Y Growth Analysis, For Regions, 2016 – 2030
- North America
- Market Size and Forecast, By Technology, 2017 – 2030 (US$ Mn)
- Market Size and Forecast, By Application, 2017 – 2030 (US$ Mn)
- Market Size and Forecast, By End User, 2017 – 2030 (US$ Mn)
- Market Size and Forecast, By Country, 2017 – 2030 (US$ Mn)
- U.S.
- Canada
- Europe
- Market Size and Forecast, By Technology, 2017 – 2030 (US$ Mn)
- Market Size and Forecast, By Application, 2017 – 2030 (US$ Mn)
- Market Size and Forecast, By End User, 2017 – 2030 (US$ Mn)
- Market Size and Forecast, By Country, 2017 – 2030 (US$ Mn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Technology, 2017 – 2030 (US$ Mn)
- Market Size and Forecast, By Application, 2017 – 2030 (US$ Mn)
- Market Size and Forecast, By End User, 2017 – 2030 (US$ Mn)
- Market Size and Forecast, By Country, 2017 – 2030 (US$ Mn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of APAC
- Latin America
- Market Size and Forecast, By Technology, 2017 – 2030 (US$ Mn)
- Market Size and Forecast, By Application, 2017 – 2030 (US$ Mn)
- Market Size and Forecast, By End User, 2017 – 2030 (US$ Mn)
- Market Size and Forecast, By Country, 2017 – 2030 (US$ Mn)
- Brazil
- Mexico
- Rest of Latin America
- Africa
- Market Size and Forecast, By Technology, 2017 – 2030 (US$ Mn)
- Market Size and Forecast, By Application, 2017 – 2030 (US$ Mn)
- Market Size and Forecast, By End User, 2017 – 2030 (US$ Mn)
- Market Size and Forecast, By Country, 2017 – 2030 (US$ Mn)
- Central Africa
- South Africa
- North Africa
- Middle East
- Market Size and Forecast, By Technology, 2017 – 2030 (US$ Mn)
- Market Size and Forecast, By Application, 2017 – 2030 (US$ Mn)
- Market Size and Forecast, By End User, 2017 – 2030 (US$ Mn)
- Market Size and Forecast, By Country, 2017 – 2030 (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Introduction
- Competitive Landscape
- Heat Map Analysis
- Company Profiles
- Danaher Corporation
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Abbott Laboratories
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Acon Laboratories, Inc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Hoffman-La Roche Ltd.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Becton, Dickinson, and Company
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Trinity Biotech Plc
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AccuBioTech Co., Ltd.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Cardinal Health, Inc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Danaher Corporation
- Section
- References
- Research Methodology
- About us and Sales Contact
Similar Reports :
Breast Cancer Diagnostic Market
Hospital-acquired Disease Testing Market
Cardiac Marker Testing Devices Market
Point-of-Care Diagnostics Market
Non-Invasive Cancer Diagnostics Market
Blood Stream Infection Testing Market
About Us:
Coherent Market Insights is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Coherent Market Insights has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We at Coherent are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defence, among different ventures present globally.
Contact Us :
Mr. Shah
Coherent Market Insights
533 Airport Boulevard, Suite 400,
Burlingame, CA 94010, United States.
U.S.A: +1-206-701-6702
UK: +44-020-8133-4027
JAPAN: +050-5539-1737
India: +91-848-285-0837
Email: sales@coherentmarketinsights.com
Website: https://www.coherentmarketinsights.com/